Minimal hepatic encephalopathy matters in daily life

World Journal of Gastroenterology

Volumn 14, Issue 23, 2008, Pages 3609-3615

  Bajaj, Jasmohan ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Diagnosis; Driving impairment; Minimal hepatic encephalopathy; Prognosis; Quality of life; Therapy

Indexed keywords

LACTULOSE; PROBIOTIC AGENT; YOGHURT;

ACCIDENT PRONENESS; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRIVING ABILITY; EDITORIAL; FIBER; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HISTORY; HUMAN; INTELLIGENCE; LEARNING DISORDER; LIVER CIRRHOSIS; LIVER FAILURE; MINIMAL HEPATIC ENCEPHALOPATHY; PREVALENCE; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; QUALITY OF LIFE; SLEEP DISORDER; WORK CAPACITY; WORKING MEMORY;

EID: 54349097527     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3609     Document Type: Editorial

References (72)

1. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42 Suppl: S45-S53
2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721
3. Mullen K, Ferenci P, Bass NM, Leevy CB, E. K. An Algorithm for the Management of Hepatic Encephalopathy. Seminars in Liver Disease 2007, 27: 32-48
4. Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology 2007; 45: 5447-5448
5. Talwalkar JA, Kamath PS. Influence of recent advances in medical management on clinical outcomes of cirrhosis. Mayo Clin Proc 2005; 80: 1501-1508
6. Noble JA, Caces MF, Steffens RA, Stinson FS. Cirrhosis hospitalization and mortality trends, 1970-87. Public Health Rep 1993; 108: 192-197
7. Vergara-Gomez M, Flavia-Olivella M, Gil-Prades M, Dalmau-Obrador B, Cordoba-Cardona J. [Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists] Gastroenterol Hepatol 2006; 29: 1-6
8. Bajaj JS, Etemadian A. Hafeezullah M. Saeon K. Testing for minimal hepatic encephalopathy in the United States: Art AASLD survey. Hepatology 2007; 45: 833-834
9. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978, 75: 462-469
10. Saxena N, Bhatia M, Joshi YK, Garg PK, Tandon RK. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. Gastroenterol Hepatol 2001; 16: 322-327
11. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-773
12. Ortiz M, Cordoba J, Jacas C. Flavia M, Esteban R, Guardia J. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 2006; 44: 104-110
13. Romero-Gomez M, Cordoba J, lover R, del Ulmo JA, Ramirez M, Rey R, de Madaria E, Montollu C, Nunez D, Flavia M, Company L, Rodrigo JM, Felipo V. Value of the critical flicker frequency in patients with minimal hepatic encephalopathly. Hepatology 2007; 45: 879-885
14. Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007; 102: 754-760
15. Meyer T, Eshelman A, Abouljoud M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc 2006; 38: 3559-3560
16. Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, Toda G, Kobayashi K, Muto Y, Tsujii T, Kawasaki H, Okita K, Tanikawa K, Fujiyama S, Shimada S. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic oncephalopathy. Hepatology 1997: 26: 1410-1414
17. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal. R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-559
18. Li YY, Nip YQ, Sha WH, Zeng Z, Yang FY, Ping L, Jia L. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10: 2397-2401
19. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-535
20. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic too! for minimal hepatic encephalopathy. J Hepatol 2007; 47: 67-73
21. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-1449
22. Kato A, Kato M, Ishii H, Ichimiya Y, Suzuki K, Kawasaki H, Yamamoto SI, Kumashiro R, Yamamoto K, Kawamura N, Hayashi N, Matsuzaki S, Terano A, Okita K, Watanabe A. Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patienta and establishment of diagnostic criteria-multicenter collaborative study in Japanese. Hepatol Res 2004; 30: 71-78
23. Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, Beyding G, Ahl B. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 2005; 20: 359-367
24. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N. Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003, 39: 320-325
25. Joebges EM, Heidemann M, Schimke N, Hecker H, Ennen JC, Weissenborn K. Bradykinesia in minimal hepatic encephalopathy is duce to disturbances in movement initiation. J Hepatol 2003; 38: 273-280
26. Bechar M, Freud M, Koll E, Koll I, Kravvic H, Stern J, Sandbank U, Bornstein B. Hepatic cirrhosis with post-shunt myelopathy. J Neurol Sci 1970; 11: 101-107
27. Weissenborn K. Clinicall features of hepatic encephallopathy. In: Zakim D. Boyer TD, editors. Hepatology. 4th ed. Philadelphia; WB Saunders, 2003; 431-444
28. Bajaj JS, Saeian K, Hafeezallah M, Hoffmann RG, Hammeke TA. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clinical Gastroenterology and Hepatology 2008; In press
29. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 37-41
30. Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 2008; 53: 307-321
31. Citro V, Milan G, Tripodi FS, Gennari A, Sorrentino P, Gallotta G, Postiglione A, Tarantino G. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. J Gastroenterol 2007; 42: 79-82
32. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, Ahl B, Manns MP, Boker KW. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004; 41: 845-851
33. Hilsalbeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J int Neuropsychol Soc 2003; 9: 847-854
34. Kalaitzakis E, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Jalan R, Bjornsson E. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int 2007; 27: 1194-1201
35. Fontana RJ, Bieliauskas LA, Lindsay KL, Back-Madruga C, Wright EC, Snow KK, Lok AS, Kronfol Z, Padmanabhan L. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 2007; 45: 1154-1163
36. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-599
37. Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 2006; 101: 1490-1496
38. Cordoba J, Cabrera J, Latait L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998; 27: 339-345.
39. Engleman HM, Hirst WS, Douglas NJ. Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome. J Sleep Res 1997; 6: 272-275
40. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, Schalin SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-49
41. Steindl PE, Finn B, Bendok B, Rothke S, Zee PC, Blei AT. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann Intern Med 1995; 123: 274-277
42. Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. Am J Gastroenterol 2007; 102: 744-753
43. Montagnese S, Middleton B, Skene DJ, Morgan MY. Sleepwake abnormalities do not correlate with neuropsychiatric performance in patients with cirrhosis (abstract). Hepatology 2008; 46: 563A
44. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R. Factors associated with poor health related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-178
45. Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003; 48: 1622-1626
46. Bao ZJ, Qiu DK, Ma X, Fan ZP, Zhang GS, Huang YQ, Yu XF, Zeng MD. Assessment of health-related quality of life in Chinese Patients with minimal hepatic encephalopathy. World J Gastroenterol 2007; 13: 3003-3008
47. Ferrer M, Cordoba J, Garin O, Olive G, Flavia M, Vargas V, Esteban R, Alonso J. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl 2006; 12: 95-104
48. Stewart CA, Smith GE. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 677-685
49. Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25 Suppl 1: 3-9
50. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodes J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890-895
51. Romero-Gomez M, Boza F, Garcia- Vaidecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-2723
52. Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver, 2002; 22: 190-197
53. Romero-Gomez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002; 37: 7811-787
54. Hartmann IJ, Groeneweg M.. Quero JC.. Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-2034
55. Maguire EA, Burgess N, Donnett JG, Frackowiak RS, Frith CD, O'Keefe J. Knowing where and getting there: a human navigation network. Science 1998; 280: 921-924
56. Evans L. The dominant role of driver behavior in traffic safety. Am J Public Health 1996; 86: 784-786
57. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10: 239-248
58. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepathology 2004; 39: 739-745
59. Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008; 47: 596-604
60. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102: 1903-1909
61. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007; 132: 1261-1269
62. Bajaj JS, Ananthakrishnan AN, McGinley E, Hottmann RG, Brasel KJ. Deleterious impact of cirrhosis on outcomes after motor vehicle crashes using the Nationwide Inpatient Sample Am J Gastroenterol 2008; In press
63. Ries ML, Jabbar BM, Schmitz TW, Trivedi MA, Gleason CE, Carlsson CM, Rowley HA, Asthana S, Johnson SC. Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in self-appraisal. J Int Neuropsychol Soc 2007; 13: 450-461
64. Starkstein SE, Jorge R, Mizrahi R, Adrian J, Robinson RG. Insight and danger in Alzheimer's disease. Eur J Neurol 2007; 14: 455-460
65. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-366
66. Conn H. In Hepatic Encephalopathy: Management with lactulose and related carbohydrates. Illinois: Medi-Ed Press, 1988
67. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007; 52: 3259-3265
68. Boca M, Vyskocil M, Mikulecky M, Ebringer L, Kolibas E, Kratochvil'ova H, Buzgova D. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies] Cas Lek Cesk 2004; 143: 324-328
69. Macbeth WA, Kass EH, Mcdermott WV Jr. Treatment of hepatic encephalopathy by alteration of intestinal flora with lactobacillus acidophilus. Lancet 1965; 1: 399-403
70. Uribe M, Dibildox M, Malpica S, Guillermo E, Villallobos A, Nieto L, Vargas F, Garcia Ramos G. Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus. Gastroenterology 1985; 88: 901-907
71. Zhao HY, Wang HJ, Lu Z, Xu SZ. Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis 2004; 5: 64-67
72. Bajaj JS, Saeian K, Christensen K, Hafeezullah M, Franco J, Varma RR, JA P, GK, Hoffmann RG, Binion DG. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008; In press